Regenerex Pharma (RGPX) Return on Equity (2011 - 2025)

Regenerex Pharma (RGPX) has 13 years of Return on Equity data on file, last reported at 0.01% in Q3 2025.

• Return on Equity for Q3 2025 came in at 0.01%, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 0.01% (changed 0.0% YoY), and the FY2025 annual result was 0.01%, down 1.0% from the prior year.
• Return on Equity advanced to 0.01% in Q3 2025 per RGPX's latest filing, from 0.01% in the prior quarter.
• Over five years, Return on Equity peaked at 0.01% in Q3 2023 and troughed at 0.0% in Q2 2021.
• A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Equity.
• The sharpest annual moves came in 2023 and 2024: Return on Equity rose 1 bps in 2023, then decreased 1 bps in 2024.
• A 5-year view of Return on Equity shows it stood at 0.0% in 2021, then grew by 3 bps to 0.0% in 2022, then surged by 471 bps to 0.01% in 2023, then sank by 66 bps to 0.0% in 2024, then soared by 119 bps to 0.01% in 2025.
• Business Quant data shows RGPX's Return on Equity at 0.01% in Q3 2025, 0.01% in Q2 2025, and 0.01% in Q1 2025.